Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul
1. FDA's top vaccine official, Peter Marks, resigns amid political turmoil. 2. Biotech sector faces pressure due to Trump's potential drug tariffs. 3. Vaccine manufacturers, including BNTX, saw shares fall around 7%. 4. Marks' departure raises concerns about future drug development policies. 5. Uncertainty looms with potential job losses within FDA under new leadership.